GnuBIO - Ownership and Business Overview

Life ScienceCompany

GnuBIO Ownership

Who owns GnuBIO?

GnuBIO is owned by Bio-Rad Laboratories. It was acquired on April 10, 2014.

GnuBIO Business Overview

Where is GnuBIO headquartered?

GnuBIO is headquartered in Cambridge, Massachusetts.

What sector is GnuBIO in?

GnuBIO is a life science company.

When was GnuBIO founded?

GnuBIO was founded in 2009.

Life Science M&A Summary in 2014

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Join Mergr to view all 237 acquisitions of life science companies in 2014, including 22 acquisitions by private equity firms, and 215 by strategics.

GnuBIO, Inc.

64 Sidney Street, Suite 380,
Cambridge, Massachusetts 02139
United States,
(617) 446-6744
www.gnubio.com

GnuBIO, Inc., is a privately-held life sciences company that has developed a droplet-based DNA sequencing platform. The innovative system developed by GnuBIO allows for a fully-integrated DNA sequencing platform that utilizes microfluidic and emulsion technology to perform complex, multiplexed reactions in droplets. This will allow both researchers and clinicians in the future to perform complete DNA sequencing workflows in a few hours instead of days.


 Subscribe to unlock this and 206,758
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.